New York, USA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The global biosurgery Market in 2021 was USD 15.93 billion, and by 2030 it will be worth USD 26.25 billion with a 5.7% CAGR. In biosurgery, surgical incisions and wounds are sealed using natural, synthetic, or semi-synthetic materials. It is frequently used to stop uncontrollable bleeding, create adhesion for sealing wounds or tissues, and restore damaged tissues and bones. The term "biosurgery" refers to the use of biological and synthetic materials during surgery to reduce the risk of infection, avoid excessive bleeding, and treat various surgical needs such as debridement of necrotic, devitalized wounds or tissues, slough, and deformities.
Make a Direct Purchase of the latest Biosurgery Market Report published in the month of Oct-2022. Click the below link to initiate the purchase:
https://www.strategicmarketresearch.com/buy-now/biosurgery-market
Biosurgery Market Insights:
- On the basis of product type, in 2021, the surgical sealants segment ruled the biosurgery market.
- In 2021, the hospital segment contributed to the biggest biosurgery market in terms of end-user.
- On the basis of surgery, the general segment led the overall biosurgery market.
- Geographically, North America contributed for the largest market with a share of nearly 32%.
Factors accelerating the Biosurgery Market growth:
Advancements in healthcare and rapid advancement in synthetic biology are expanding the overall growth of the market.
- Biosurgery market growth is due to recent advancements in the field of surgery. The introduction of surgical robots has resulted in an increase in the number of procedures since robotic surgery decreases human touch and is powered by powerful computational technology, lowering the chance of error. As a result, these improvements increase the demand for biosurgery products and favourably influence market growth. The increasing use of biosurgery for effective blood loss management via minimally invasive hemostatic agents and surgical sealants rather than conventional staples and sutures is driving the market. Furthermore, market growth can be linked to significant healthcare structure investments and numerous research and development initiatives.
- The market for biosurgery will grow significantly due to the quick breakthroughs in synthetic biology for regenerative tissue medicine. The development of improved biologics by businesses in industrialized nations also fosters the market for biosurgery's steady expansion.
Biosurgery Market: A thorough Segmentation Analysis
The worldwide Biosurgery Market segmentation has been performed on the basis of product type, application, End-user, and region.
By Product:
• Bone Graft Substitutes
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Demineralized bone matrix
- Other Bone-Graft Substitutes
• Soft-tissue attachments
- Synthetic meshes
- Biological meshes
• Xenografts
• Allografts
• Hemostatic agents
- Combination hemostatic agents
- Thrombin-based hemostatic agents
- Oxidized regenerated cellulose-based hemostatic agents
• Surgical sealants and adhesives
- Natural/Biological Sealants and Adhesives
• Collagen
• Gelatin
• Fibrin
• Albumin
• Others
- Synthetic and Semi-Synthetic Sealants and Adhesives
• Cyanoacrylate-Based Sealants and Adhesives
• Urethane-Based Sealants and Adhesives
• Peg Hydrogels
• Other
• Adhesion Barriers
- Synthetic Adhesion Barriers
• Regenerated Cellulose-Based Adhesion Barriers
• Peg-Based Adhesion Barriers
• Hyaluronic Acid-Based Adhesion Barriers
• Other Synthetic Adhesion Barriers
- Natural Adhesion Barriers
• Fibrin-Based Adhesion Barriers
• Collagen & Protein Adhesion Barriers
• Staple-Line Reinforcement Agents
By surgery:
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Urological Surgery
- Thoracic Surgery
- Others
By End-User
- Clinics
- Hospitals
- Ambulatory surgical centers
- Others
By Region
North America
- Mexico
- Canada
- United States
- Rest of North America
Europe
- United Kingdom
- France
- Italy
- Germany
- Spain
- Rest of Europe
Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia Pacific
LAMEA
- Uruguay
- Brazil
- Saudi Arabia
- Argentina
- Rest of LAMEA
To get a first-hand overview of the report, Request a Sample at
https://www.strategicmarketresearch.com/request-sample/biosurgery-market
On the basis of product type, in 2021, the surgical sealants segment ruled the biosurgery market. The prevalence of back discomfort and sports-related injuries has expanded the market for surgical sealants & adhesives. The immune system of the body also accepts biomaterials like fibrin and collagen-based adhesives quite well. Additionally, synthetic and artificial sealants have strong adhesive properties, which may be required in damage cases involving "awkward places."
On the basis of surgery, the general segment led the overall biosurgery market. It is because a general surgeon can perform a wide range of operations. A general surgeon, for instance, can support the treatment of hernias, hemorrhoids, colonoscopy, breast surgery, and even the removal of the appendix or gall bladder.
In 2021, the hospital segment contributed to the biggest biosurgery market in terms of end-user. It results from hospitals performing a growing amount of general and gynecological surgery compared to other end-use segments. The market for biosurgery has also been encouraged by the rise of contemporary biosurgery treatment methods and the expansion of multispecialty institutions.
Geographically, North America contributed for the largest market with a share of nearly 32%. It is driven by the increased prevalence of obesity, raising the demand for sophisticated surgical treatments, the frequency of orthopedic surgeries, the amount of money spent on healthcare, and public knowledge of the advantages. A well-developed healthcare infrastructure and cutting-edge technologies and treatments are further elements promoting market expansion in the area.
| Report Attribute | Details | |
| Forecast Period | 2021 - 2030 | |
| The market size value in 2021 | USD 15.93 Billion | |
| The revenue forecast in 2030 | USD 26.25 Billion | |
| Growth rate | 5.7% | |
| The base year for estimation | 2021 | |
| Historical data | 2017 - 2020 | |
| Quantitative units | Revenue in USD Billion and CAGR from 2021 to 2030 | |
| Report coverage | Revenue forecast, , competitive landscape, company ranking, growth factors, and trends | |
| Segmentation | By Product Type, By Surgery, By Origin, By End User, and By Region. | |
| By Product Type | Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents | |
| By Surgery | Orthopedic, General, Neurological, Cardiovascular, Reconstructive, Gynecological, Urological, and Thoracic | |
| By Origin | Biological, Synthetic | |
| By End-User | Hospitals, Ambulatory Surgical Centers, Clinics, and Others | |
| By Region | North America, Asia Pacific, Europe, and LAMEA | |
| Country Scope | U.S., Canada, France, U.K., China, Germany, Japan, India, Mexico, South Korea, Brazil, U.A.E., etc. | |
| Company Usability Profiles | Johnson & Johnson, Baxter International Inc., Medtronic Plc, Becton, Dickinson & Co., B. Braun Melsungen AG, Stryker Corp., Integra Lifesciences Holdings Corp., CSL Ltd., Hemostasis LLC., Pfizer Inc., Cyrolife Inc., Zimmer Biomet, Kuros Biosciences AG ,Orthofix Medical Inc., Smiths & Nephew Plc, ecm biosurgery, Genzyme biosurgery | |
Key players in Biosurgery Market:
- Baxter International Inc.
- Medtronic Plc
- CSI Ltd
- Tissue Regenix Group Plc
- Stryker Corp.
- Integra Lifesciences Holdings Corp.
- Becton, Dickinson & Co
- Pfizer Inc.
- Hemostasis LLC
- Smiths & Nephew Plc
- Zimmer Biomet
- Kuros Biosciences AG
- Orthofix Medical Inc.
- Cyrolife Inc.
- Tissue Regenix Group Plc
- Betatech Medical
- Meril Lifesciences Pvt. Ltd.
- RTI Surgicals
- Samyang Holdings Corp.
- Johnson and johnson
Before initiating a purchase, make a Pre-order enquiry and get a detailed overview of the content of the report.
https://www.strategicmarketresearch.com/pre-order-enquiry/biosurgery-market
Recent Development
- In September 2022, Arch Therapeutics, Inc., which is a marketer, & developer of novel self assembling wound care & biosurgical products announced the start of a multi-site clinical study to accelerate and augment payor adoption & differentiate the key benefits of the AC5® Advanced Wound System ("AC5") in treating difficult wounds.
- An industry pioneer in the creation of self-adhesive surgical sealant films, Tissuemed, Ltd., a privately held company with its headquarters in Leeds, England, was acquired by Becton, Dickinson, and Company.
- GTCR, a renowned private equity firm, announced that Barron Precision Instruments, LLC, a founder-owned medical device company specializing in ocular surgery products, has been acquired by Corza Medical, a major global manufacturer of cutting-edge surgical technology.
Related Reports
Spinal Implants and Surgery Devices Market
The spinal implants and surgery devices Market report provides an overview of its growth factors, opportunities, challenges, etc. The spinal implants and surgery devices Market in 2021 was $11.42 billion, and it will be $18.08 billion by 2030, at a 5.23% CAGR during 2021-2030. The rising incidence of spinal instability problems is influencing its growth rate. Companies in this market are Medtronic, RTI Surgical, Stryker Corporation, Globus medical, etc.
Electrosurgical Devices Market
SMR's Electrosurgical Devices Market Report provides an analysis of its driving factors, challenges, restraints, etc. The Electrosurgical Devices Market in 2021 was USD 3.18million and will reach USD 5.25 billion by 2030 with a 5.73% CAGR. The increased number of surgical procedures and the rising geriatric population are the factors expanding the market. Major companies in this market are Smith and Nephew, Boston Scientific, Olympus Corporation, Covidien plc, etc.
Surgical Microscopes Market
SMR report on the Surgical Microscopes Market provides an in-depth analysis of its restraints, challenges, augmenting factors, etc. The Surgical Microscopes Market in 2021 was USD 1.77.087 million and will reach USD 2928.17 million, with an 11.75% CAGR. Factors like technological advancements and growth in the number of surgeries are expanding the growth of the market. Organizations in this market are Olympus Corp., Alcon Inc., Topcon Corporation, Danaher Corporation, etc.
Minimally Invasive Surgical Instruments Market
The Minimally Invasive Surgical Instruments Market Report offers an analysis of its drivers, opportunities, challenges, etc. The Minimally Invasive Surgical Instruments Market in 2021 was USD 22.38 billion, and it will reach USD 43.76 billion by 2030 at a 7.21% CAGR. The rising incidence of surgeries worldwide is accelerating the growth of the market. Vital players in the market are Johnson & Johnson, HOYA Corporation, Medtronic, Abbott Laboratories, etc.
Congestive Heart Failure (CHF) Treatment Devices Market
SMR's Congestive Heart Failure (CHF) Treatment Devices Market report offers an overview of its growth factors, restraints, opportunities, etc. The Congestive Heart Failure (CHF) Treatment Devices Market worth in 2021 was USD 17.53 Billion and will be USD 35.96 Billion by 2030 with an 8.31% CAGR. High-stress levels, dietary habits, and lifestyle changes are supporting the growth of the market. Players in this market are Abiomed, Medtronic, CVRx, Berlin Heart GmbH, etc.
About Us:
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup which is in the Introduction stage of the Product Life cycle or an established one which is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.
Contact Us:
Strategic Market Research LLP.
Sunil Kumar
India: +91-8260836500
Email: info@strategicmarketresearch.com
Web: https://www.strategicmarketresearch.com
Blog: https://www.strategicmarketresearch.com/blog
Blog: https://www.strategicmarketresearch.com/blogs/metaverse-statistics
Press Release: https://www.strategicmarketresearch.com/press-releases
Connect Us:
LinkedIn: https://www.linkedin.com/company/strategic-market-research/
Twitter: https://twitter.com/smrstrategic
Facebook: https://www.facebook.com/StrategicMarketResearch
Instagram: https://www.instagram.com/strategicmarketresearchsmr/
